📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
4 articles
AVG GRADE
HIGH
score: 0.50
SENTIMENT
BULLISH
TOTAL VIEWS
8
VSTM Latest News & AI Sentiment Analysis
4 articles · Grade: HIGH · Real-time AI-graded coverage
RECENT COVERAGE · 5 ARTICLES
10 Best Stocks Under $10 That Could Triple
This article presents a listicle-style investment recommendation piece focused on small-cap equities trading below $10 per share, citing...
Is Verastem, Inc. (VSTM)’s KRAS-Targeted Combination Therapy a Breakthrough for Pancreatic Cancer?
Verastem (VSTM) disclosed updated clinical trial data from its KRAS-targeted combination therapy program, specifically results from the...
Verastem, Inc. (VSTM) Discusses Preliminary TARGET-D 101 Data for VS-7375 in KRAS G12D Mutated Cancers - Slideshow (NASDAQ:VSTM) 2026-06-24
Verastem (VSTM) presented preliminary TARGET-D 101 trial data for its investigational therapy VS-7375, targeting KRAS G12D mutations in...
Verastem, Inc. (VSTM) Discusses Preliminary TARGET-D 101 Data for VS-7375 in KRAS G12D Mutated Cancers Transcript
Verastem (VSTM) has disclosed preliminary efficacy and safety findings from the TARGET-D 101 trial evaluating VS-7375, a targeted...
Verastem: 'Buy' Positive RAMP-205 Data And Extensive VS-7375 Registration Program (VSTM)
Verastem (VSTM) maintains a Buy rating centered on clinical progress in its oncology pipeline, specifically positive data from the...
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice